Overview of recent advances in metastatic triple negative breast cancer

doi:10.5306/wjco.v12.i3.164

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11780)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-6) series.

Item

Count

PDF

891

WORD

214

HTML

7712

Tables (1-6)

337

Sum=9154

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

354

Download

717

Sum=1071

Publishing Process of This Article

Item

Count

Browse

458

Download

1097

Sum=1555

Mar 24, 2021 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (48)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Mar 24, 2021; 12(3): 164-182
Published online Mar 24, 2021. doi: 10.5306/wjco.v12.i3.164

Table 5 Pivotal Phase III studies of poly adenosine diphosphate ribose polymerase inhibitors in patients with germline BRCA1/BRCA2 mutations

Trial	n	Drug	Median PFS (mo) 1^st line	Media PFS (mo) ≥ 1 line	Media OS (mo) 1^st line	Media OS (mo) ≥ 1 line	Ref.
OLYMPIAD	296	Olaparib		7.3		19.3	Robson et al[67], 2017
EMBRCA	431	Talazoparib		8.6		19.6	Litton et al[69], 2020
BROCADE3 (1^st line)	337	Veliparib	14.5		33.5		Bardia et al[77], 2020

PFS: Progression free survival; OS: Overall survival.

Citation: O'Reilly D, Sendi MA, Kelly CM. Overview of recent advances in metastatic triple negative breast cancer. World J Clin Oncol 2021; 12(3): 164-182
URL: https://www.wjgnet.com/2218-4333/full/v12/i3/164.htm
DOI: https://dx.doi.org/10.5306/wjco.v12.i3.164